Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Basic fibroblast growth factor preserves rabbit adipose-derived mesenchymal stromal cells in serum-free culture.

Kuncorojakti S., Aswin A., Diyantoro D., Susilowati H., Yudaniayanti IS., Susanti L.

Animal Study on Face & Skin, published in J Vet Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Vet Sci (2026)
Country
Korea (South)
Reported sample size
—
Source database
PubMed
PMID
42225607
PMCID
PMC13236468
DOI
10.4142/jvs.25154

Abstract (original English)

Importance Fetal bovine serum (FBS) is widely used for mesenchymal stromal cell (MSC) expansion but carries risks of contamination, batch variability, and xenogeneic exposure that can compromise reproducibility and downstream therapeutic use. Objective To develop and evaluate a rabbit adipose-derived mesenchymal stromal cell (Rab-ADMSC) serum-free medium (SFM) supplemented with growth factors that maintains key MSC characteristics. Methods Rab-ADMSCs were isolated from 3 male New Zealand White rabbits. Basic fibroblast growth factor (bFGF), transforming growth factor-β1, and insulin-like growth factor-1 were screened for support of cell viability in SFM. Cells were then cultured in α-Minimum Essential Medium with 10% FBS or in SFM supplemented with bFGF and assessed for morphology, proliferation, expression of stemness- and senescence-associated transcripts, surface marker expression, and tri-lineage differentiation potential. Results SFM supplemented with bFGF preserved fibroblast-like morphology and supported Rab-ADMSC expansion. Transcript levels of stemness-associated markers and senescence-associated markers were comparable between culture conditions. Rab-ADMSCs retained osteogenic, adipogenic, and chondrogenic differentiation potential. Flow cytometry showed higher expression of CD81, CD49f, and CD29 in the SFM plus bFGF condition, whereas CD34 and CD45 remained low in bo

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMesenchymal Stem CellsFibroblast Growth Factor 2RabbitsMaleCulture Media, Serum-FreeAdipose TissueCell Culture TechniquesCell DifferentiationCell Proliferation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research